Development of cell lines stably expressing human immunodeficiency virus type 1 proteins for studies in encapsidation and gene transfer

References

1. Ausubel F., Brent R., Kingston R., Moore D., Seidman J., Smith J., Struhl K. 1991 Current Protocols in Molecular Biology New York: Wiley-Interscience;
   [Google Scholar]
2. Banerjee R., Bekes J. G., Tarcsafalvi A., Sperber K., Deak G., Choi H.-S., Paronetto F., Holland J., Acs G. 1992; Productive nonlytic human immunodeficiency virus type 1 replication in a newly established human leukemia cell line. Proceedings of the National Academy of Science, USA 89:9996–10000
   [Google Scholar]
3. Carroll R., Lin J. T., Dacquel E. J., Mosca J. D., Burke D. S., St Louis D. C. 1994; A human immunodeficiency virus type 1 (HIV-1)-based retroviral vector system utilizing stable HIV-1 packaging cell lines. Journal of Virology 68:6047–6051
   [Google Scholar]
4. Kaye J., Richardson J., Lever A. 1995; Cis-acting sequences involved in human immunodeficiency virus type 1 RNA packaging. Journal of Virology 69:6588–6592
   [Google Scholar]
5. Kowalski M., Potz J., Basiripour L., Dorfman T., Goh W. C., Terwilliger E., Dayton A., Rosen C., Haseltine W., Sodroski J. 1987; Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1. Science 237:1351–1355
   [Google Scholar]
6. Krôusslich H. G. 1992; Specific inhibitor of human immunodeficiency virus proteinase prevents the cytotoxic effects of a single-chain proteinase dimer and restores particle formation. Journal of Virology 66:567–572
   [Google Scholar]
7. Krôusslich H. G., Ochsenbauer C., Traenckner A. M., Mergener K., Fäcke M., Gelderblom H. R., Bosch V. 1993; Analysis of protein expression and virus-like particle formation in mammalian cell lines stably expressing HIV-1 gag and env gene products with or without active HIV proteinase. Virology 192:605–617
   [Google Scholar]
8. Leibovitz A., Stinson J., McCombs W., McCoy C., Mazur K., Mabry N. 1976; Classification of human colorectal adenocarcinoma cell lines. Cancer Research 36:4562–4569
   [Google Scholar]
9. McBride M. S., Schwartz M. D., Panganiban A. T. 1997; Efficient encapsidation of human immunodeficiency virus type 1 vectors and further characterization of cis elements required for encapsidation. Journal of Virology 71:4544–4554
   [Google Scholar]
10. Maddon P. J., Dalgleish A. G., McDougal J. S., Clapham P. R., Weiss R. A., Axel R. 1986; The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell 47:333–335
    [Google Scholar]
11. Moses A. V., Ibanez C., Gaynor R., Ghazal P., Nelson J. A. 1994; Differential role of long terminal repeat control elements for the regulation of basal and Tat-mediated transcription of the human immunodeficiency virus in stimulated and unstimulated primary human macrophages. Journal of Virology 68:298–307
    [Google Scholar]
12. Parolin C., Dorfman T., Palù G., Göttlinger H., Sodroski J. 1994; Analysis in human immunodeficiency virus type 1 vectors of cis-acting sequences that affect gene transfer into human lymphocytes. Journal of Virology 68:3888–3895
    [Google Scholar]
13. Potts B. J. 1990; ‘Mini’ reverse transcriptase (RT) assay. In Techniques in HIV Research pp. 103–106 Aldovini A., Walker B. D. Edited by New York: Stockton Press;
    [Google Scholar]
14. Poznansky M., Lever A., Bergeron L., Haseltine W., Sodroski J. 1991; Gene transfer into human lymphocytes by a defective human immunodeficiency virus type 1 vector. Journal of Virology 65:532–536
    [Google Scholar]
15. Richardson J. H., Child L. A., Lever A. M. L. 1993; Packaging of human immunodeficiency virus type 1 RNA requires cis-acting sequences outside the 5′ leader region. Journal of Virology 67:3997–4005
    [Google Scholar]
16. Richardson J. H., Kaye J. F., Child L. A., Lever A. M. L. 1995; Helper virus-free transfer of human immunodeficiency virus type 1 vectors. Journal of General Virology 76:691–696
    [Google Scholar]
17. Rogel M., Wu L., Emerman M. 1995; The human immunodeficiency virus type 1 vpr gene prevents cell proliferation during chronic infection. Journal of Virology 69:882–888
    [Google Scholar]
18. Schubert U., Strebel K. 1994; Differential activities of the human immunodeficiency virus type 1-encoded Vpu protein are regulated by phosphorylation and occur in different cellular compartments. Journal of Virology 68:2260–2271
    [Google Scholar]
19. Tsuchiya S., Yamabe M., Yamaguchi Y., Kobayashi Y., Konno T., Tada K. 1980; Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). International Journal of Cancer 26:171–176
    [Google Scholar]
20. Willey R. L., Maldarelli F., Martin M. A., Strebel K. 1992; Human immunodeficiency virus type 1 Vpu protein induces rapid degradation of CD4. Journal of Virology 66:7193–7200
    [Google Scholar]
21. Yao X. J., Friborg J., Checroune F., Gratton S., Boisvert F., Sekaly R. P., Cohen E. A. 1995; Degradation of CD4 induced by human immunodeficiency virus type 1 Vpu protein: a predicted alpha-helix structure in the proximal cytoplasmic region of CD4 contributes to Vpu sensitivity. Virology 209:615–623
    [Google Scholar]
22. Yu H., Rabson A. B., Kaul M., Ron Y., Dougherty J. P. 1996; Inducible human immunodeficiency virus type 1 packaging cell lines. Journal of Virology 70:4530–4537
    [Google Scholar]